I think that was originally linked but got changed to the £30 to Elsevier version for some reason.
its slow-release oral minoxidil formulation called MINX. AI helped with the formulation [1].
its in in similar category as VDPHL01. Hundreds of millions if not a billion dollars has been invested into Veradermics, and their main product is VDPHL01 (also an extended-release oral formulation).
Wheres my follicles dammit?
Only for values of 'all' that exclude well-connected members of the billionaire class and their select associates.
Ketamin should have huge impacts on neuro/brain plasticity when used properly (i.e. in therapy)
In therapy as well.
No? Well fancy that! :)
Please. Please let some people with power and influence understand this lesson sooner rather than later. I understand the reasons that's unlikely to occur, but usually the impact isn't quite so drastic and expensive as this is. Just because something is new and shiny doesn't mean that it'll produce the outcomes you need at the other end, and until it's shown that capability your approach to it should be MODERATE.
It's also worth mentioning that drug development timelines typically exceed the interval in which these technologies have been available (or at least effective). Measuring impact will take a long time.
I've been taking it without significant side effects for ~15 years, so I'm not worried, although at this point it's losing its main effect as well.